The total number of records retrieved from this search are 34. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_3386	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3387	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3388	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3389	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result60% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3390	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result55% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3391	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result50% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3392	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result70% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3393	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result50% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3394	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result40% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3395	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3396	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3397	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3398	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result80% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3399	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result70% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3400	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result60% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3401	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result80% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3402	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result70% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3403	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1975	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result50% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_4587	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4588	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4589	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4590	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4591	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4592	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4593	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result100% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4594	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4595	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4596	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4597	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4598	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4599	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4600	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4601	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4602	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1975	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225